A Study to Investigate the Efficacy and Safety of Belumosudil Compared With Best Available Therapy in Participants Aged 12 Years or Older With Chronic Graft-versus-host Disease
Clinical trial NCT07771439 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07771439
- Sponsor
- Sanofi
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-07
- Primary completion
- 2029-09-14
- Enrollment
- 356
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.